Coronavirus Disease 2019 (COVID-19) in pediatric emergency. Presentation and disposition

Roaa S Jamjoom1

  • 1Department of Emergency Medicine, Faculty of Medicine King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail. rsjamjoom@kau.edu.sa.

Saudi Medical Journal
|January 5, 2021
PubMed

Insights

Pediatric coronavirus disease 2019 (COVID-19) patients in the emergency department frequently presented with fever and cough. The gastrointestinal tract was the second most affected system, leading to the most return visits.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) emerged as a global pandemic.
  • Understanding the clinical characteristics of pediatric COVID-19 is crucial for effective management.
  • Pediatric presentations of COVID-19 can vary significantly.

Purpose of the Study:

  • To analyze the demographics of pediatric patients with COVID-19 in the emergency department.
  • To identify common clinical presentations and outcomes for pediatric COVID-19 cases.
  • To investigate factors such as contact history, return visits, and patient disposition.

Main Methods:

  • Retrospective chart review of confirmed pediatric COVID-19 cases.
  • Data collected from March 2020 to June 2020.
  • Analysis of patient demographics, symptoms, treatments, and outcomes.

Main Results:

  • Fifty-two pediatric patients with COVID-19 were identified.
  • Fever (85%) and cough (48%) were the most common symptoms.
  • Gastrointestinal symptoms, particularly diarrhea (23%), were prevalent and led to return visits.

Conclusions:

  • The gastrointestinal tract was the second most affected system in pediatric COVID-19 cases.
  • Diarrhea was a significant factor contributing to emergency department return visits.
  • COVID-19 presents clinical and operational challenges due to its diverse manifestations in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
271
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
573
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
298